Herpes Simplex Virus type 1 (HSV-1) IgG ELISA (Mouse/Rat) kit

Specifications

Product Data
Description	Herpes Simplex Virus type 1 (HSV-1) IgG ELISA (Mouse/Rat) kit
Size	1 x 96 wells
Format	8x12 divisible strips
Assay Type	Solid Phase Sandwich ELISA
Assay Length	3 hours
Signal	Colorimetric
Sample Type	Serum
Sample Volume	10 µl/well
Specificity	This kit is used for quantitative detection Herpes Simplex Virus type 1 (HSV-1) IgG ELISA (Mous
Reactivity	Mouse, Rat
Components	1. Microwell coated with HSV-1 antigen: 12x8x1 2. Sample Diluent: 1 bottle (ready to use): 22 ml 3. Calibrator: 1 Vial (ready to use): 1ml 4. Positive Control: 1 vial (ready to use): 1ml 5. Negative Control: 1 vial (ready to use): 1ml 6. Enzyme conjugate: 1 bottle (ready to use): 12ml 7. TMB Substrate: 1 bottle (ready to use): 12ml 8. Stop Solution: 1 bottle (ready to use): 12ml 9. Wash concentrate 20X: 1 bottle: 25ml
Background	HSV-1 and 2 are virtually identical, sharing approximately 50% of their DNA and have over 80% of common antigens. Both types infect the body's mucosal surfaces, usually the mouth or genitals, and then establish latency in the nervous system. Several recent studies have shown the association of more than a dozen herpes viruses with cancer in man and various animals; for example with lymphoma and with squamous cell carcinoma of the lip and cancer of the cervix. HSV type 1 is the cause of most orofacial herpes and HSV encephalitis; type 2 is the primary cause of initial and recurrent genital herpes and neonatal HSV. Reactivation of latent HSV infection is a frequent complication of immunosuppression due to cancer, transplantation and AIDS. Asymptomatic genital shedding of HSV-2 is more common than HSV-1 and occurs more frequently during the first 3 months after acquisition of primary type 2 disease than during later periods. The presence of HSV IgG antibody is indicative of previous exposure. A significant increases in HSV IgG is an indicative of reactivation, current or recent infection. IgM antibody is present after primary HSV infection.The effect of virus dose and animal age on the appearance of acute and latent neurologic infection bu HSV1 and HSV2 was studied in Balb/c and ICR mice inoculated in the footpad. At low viral doses, HSV2 was found to be 1,500 times more neurovirulent than HSV1. The Mp strain of herpes simplex virus type 1 ( HSV1 ) induced a persistent infection in the mouse C 1300 neuronal cell line ( clone N 115 ). C 1300 cultures infected at an MOI of 0.01 or 0.001 survived the initial infection and continued to produce infectious virus and viral antigens for 185 days and 31 days, respectively.

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.